The Incidence of Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure Detected by Implantable Loop Recorders

• DOI: 10.1016/j.jscai.2024.101930
• Publication Date: 2024-06-05T15:24:43Z
• Authors: Komal Imtiaz; Mohammed Ebrahim; Jianli Niu; Jonathan Roberts
• Keywords: Closure (psychology)

Patent foramen ovale (PFO) is seen in 25% of the general population but up to 50% patients ≤60 years old with cryptogenic strokes. Trials have shown that PFO closure vs medical therapy reduces risk future may cause atrial fibrillation (AF), prior trials reporting an incidence 2% 11.9%. However, true AF after unknown due limitations studies for long-term monitoring.